HARPOON THERAPEUTICS INC (HARP)
US41358P2056 - Common Stock
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -30.50M | -67.73M | -116.72M | -49.91M | -55.57M | |||
| Depreciation Amortization | 1.95M | 2.36M | 2.19M | 2.08M | 900.00K | |||
| Change In Working Capital | -42.27M | -33.58M | -19.91M | 33.43M | 49.05M | |||
| Other non cash items | 1.44M | 9.77M | 12.29M | 5.78M | 2.73M | |||
| OPERATING CASH FLOW | -69.38M | -89.18M | -122.15M | -8.62M | -2.89M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -350.00K | -100.00K | -680.00K | -3.52M | |||
| Other Investing Activity | 3.40M | 90.08M | 34.45M | -62.94M | -65.80M | |||
| INVESTING CASH FLOW | 3.29M | 89.74M | 34.35M | -63.63M | -69.32M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 9.61M | 6.37M | 111.52M | 4.68M | 71.45M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 33.00M | 6.37M | 111.52M | 4.68M | 71.45M | |||
| CHANGE IN CASH | -33.09M | 6.93M | 23.72M | -67.57M | -760.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -69.38M | -89.18M | -122.15M | -8.62M | -2.89M | |||
| Capital Expenditure | N/A | -350.00K | -100.00K | -680.00K | -3.52M | |||
| FREE CASH FLOW | -69.50M | -89.53M | -122.25M | -9.30M | -6.41M | |||
All data in USD